"Chronic Epstein-Barr virus infection" syndrome and polymyalgia rheumatica.

Abstract

Twenty-three patients with polymyalgia rheumatica (PMR) followed in an academic rheumatology practice frequently reported symptoms commonly found in the recently described "chronic fatigue syndrome" or "chronic Epstein-Barr infection syndrome." These symptoms persisted for months after treatment had reduced the severity of the myalgias and lowered the sedimentation rate: periodically disabling fatigue (33%), recurrent pharyngitis (30%), sleep disorder (65%) and arthralgias (70%). However, antibody titers to Epstein-Barr virus in the patients with PMR were not significantly different from those in age and sex matched control subjects.

• Authors: D Buchwald, J L Sullivan, S Leddy, A L Komaroff
• Journal: The Journal of rheumatology (J Rheumatol) Vol. 15 Issue 3 Pg. 479-82 (Mar 1988) ISSN: 0315-162X [Print] Canada
• PMID: 2837573 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• Antibodies, Viral

Topics

• Aged
• Antibodies, Viral (analysis)
• Blood Sedimentation
• Chronic Disease
• Fatigue (complications)
• Headache (complications)
• Herpesvirus 4, Human (immunology)
• Humans
• Infectious Mononucleosis (blood, complications, immunology, physiopathology)
• Muscles (physiopathology)
• Pain
• Polymyalgia Rheumatica (blood, complications, immunology, physiopathology)
• Syndrome